News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Casey’s General Stores Round Up for MDA

Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

Blog Post

MDA Awards Clinical Research Network Grant to CMT Researcher Michael Shy for Inherited Neuropathies Consortium

MDA logo
Blog Post

In a Letter to the Duchenne Community, Santhera Announces Positive Results of Phase 2 Vamorolone Study, EMA’s Review of Puldysa to Treat Symptoms of DMD

Blog Post

MDA Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research

baby girl
Blog Post

Biogen Announces Positive Long-Term Results from Phase 2 Study of Spinraza to Treat SMA in Pre-Symptomatic Infants

Blog Post

The ALS Association, ALS Finding A Cure, and MDA Co-Fund Clinical Trial Grant to Study Restoring Immune System Function to Treat ALS

Blog Post

Scholar Rock Announces Positive Results from Phase 1 Study of SRK-015 to Treat SMA

Blog Post

US House Passes Newborn Screening Reauthorization

Blog Post

MDA Awards Venture Philanthropy Funding to Rachelle Crosbie to Develop a Novel Membrane-Stabilizing Drug for DMD